Vicarious Surgical buyers right this moment voted to close down and liquidate the surgical robotics developer instantly. The information was first reported by our sister web site MassDevice. Vicarious CEO Stephen From, who joined the corporate in 2025 and misplaced his job right this moment together with the opposite remaining Vicarious Surgical workers, mentioned he was in talks with a possible purchaser in current days.
As a substitute, medical machine OEMs have signed non-disclosure agreements to entry the corporateâs knowledge room whereas Vicarious Surgical belongings are auctioned off.
âI used to be so impressed with what they had been in a position to do,â From informed MassDevice. âThatâs why Iâm so mad. Iâm so annoyed. That is the kind of platform that deserves to be within the clinic and within the hospitals, serving to sufferers. Thatâs a disgrace.â
The corporate raised about $300 million in complete â most of that from a particular objective acquisition firm (SPAC) merger in 2021 â however couldn’t get its R&D program to a design freeze, which From hoped to realize by the top of 2026.
The corporate was spending about $50 million yr when From joined the corporate in August 2025, he mentioned, and restructuring received the burn charge under $20 million by the start of this yr with out pushing again the end-of-2026 design freeze goal.
However by then the corporateâs market capitalization had dropped sufficient that the NYSE put Vicarious Surgical on its watch listing for potential delisting, and that killed the corporateâs efforts to boost additional cash.
âWe received this notification, and the bankers, rightly so, mentioned itâs over,â From mentioned. â⊠With the cash we had within the financial institution once we went out in January, we mentioned one other $10 million internet would get us to the top of the yr.â
The Vicarious Surgical board unanimously proposed the closure and liquidation, saying it couldn’t predict whether or not there can be something left to repay buyers. An assignee will liquidate the soft-tissue robotics developerâs belongings to settle excellent obligations.
âSince inception, we have now skilled recurring working losses and damaging money flows, and we count on to proceed to generate working losses and eat important money assets for the foreseeable future,â the corporate mentioned forward of right this momentâs particular assembly of stockholders, reporting practically $3.7 million of money, money equivalents and short-term investments as of March 31.
âWe don’t count on our money and money equivalents to be ample to proceed as a going concern for any important time frame,â the corporate continued. âThough we’re presently exploring numerous strategic options, together with strategic companions and financing alternatives, it’s unlikely that these strategic options will likely be profitable within the subsequent few weeks previous to our money place attending to the purpose that we might want to pursue our winding down and dissolution. Thus far, we have now been unable to safe extra fairness, debt or different financing and have been unsuccessful in our efforts to draw a purchaser for our enterprise.â
The corporate mentioned there are âuncertainties as to the final word quantity of our liabilities,â however reported $9 million in complete liabilities on the finish of March and $12.6 million in belongings.
The corporate misplaced $7.3 million that quarter, following a $50.2 million loss in 2025 and $63 million loss the yr earlier than.
As of March 9, Vicarious reported 26 workers: 11 in R&D, regulatory and medical, eight in manufacturing and high quality assurance, and 7 in advertising, gross sales, and administration. The corporate mentioned it leases 42,000-square-feet of workplace house at its Waltham, Massachusetts headquarters.
Since then, Vicarious Surgical CFO Sarah Romano has tendered her resignation to take the identical function at SS Improvements on Aug. 3.
The put up Vicarious Surgical formally shutting down appeared first on The Robotic Report.
